Tatva Chintan IPO

Tatva Chintan Pharma Chem

₹13,949 /13 sharesMinimum Investment

Tatva Chintan IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
16 Jul ‘21 - 20 Jul ‘21₹13,94913₹1,073 - ₹1,083
Issue SizeIPO Doc
500.00Cr
RHP PDF

Subscription Status As on 20 Jul '21, 5:00 PM

  • Retail Individual Investor
    35.34x
  • Non-Institutional Investor
    512.22x
  • Qualified Institutional Buyers
    185.23x

About Tatva Chintan

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is into the manufacture of a diverse portfolio of Structure Directing Agents (SDAs), Phase Transfer Catalysts (PTCs), electrolyte salts for super-capacitor batteries, and Pharmaceutical and Agrochemical Intermediates and other Specialty Chemicals (PASC). ;
Parent Organisation
Tatva Chintan Pharma Chem
Founded
1996
Managing Director
Chintan Nitinkumar Shah
Tatva Chintan Pharma Chem IPO - Business, financials, IPO details & analysis | Upcoming IPO 2021

Strengths & Risks

  • Leading manufacturer of SDAs and PTCs with consistent quality
  • Global presence with a wide customer base across various industries having high entry barriers
  • Diversified specialized product portfolio requiring strong technical know-how
  • Modern manufacturing facilities with a focus on ‘green’ chemistry processes
  • Strong R&D capabilities
  • Experienced Promoters with a strong management team
  • Robust Financial Performance
  • Impact of COVID-19
  • Unplanned slowdowns or shutdowns in its manufacturing operations
  • Failure to comply with the quality standards and technical specifications prescribed by its institutional customers
  • Increase in the cost of raw materials
  • Multiple country risks
  • Dependency on a limited number of suppliers for certain raw materials
  • A significant portion of its revenue from a few customers
  • Non-compliance with and changes in, safety, health, environmental, and labor laws
  • Any downgrade in its credit rating

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
For Tatva Chintan IPO, eligible investors can apply as
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ

ABOUT GROWW